Velphoro was well tolerated with long-term use*1

GI adverse events were mild to moderate, and resolved without intervention1

Adverse events occurring in >5% of patients during the 52-week clinical study1,2:


Velphoro is selective, with few drug or metabolic interactions

Velphoro is a powerful, selective phosphate binder that doesn't bind to vitamins A, D, E, K, or folic acid, as sevelamer does.1,3

Patients taking Velphoro require no additional monitoring for iron management